Deutsche Bank Aktiengesellschaft »

Celldex Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 40k 33.99
2024-06-30 $1.6M 45k 37.01
2024-03-31 $1.9M 46k 41.97
2023-12-31 $1.4M 36k 39.66
2023-09-30 $1.0M 37k 27.52
2023-06-30 $1.2M 34k 33.93
2023-03-31 $1.6M 45k 35.98
2022-12-31 $1.6M 36k 44.57
2022-09-30 $942k 34k 28.11
2022-06-30 $4.6M 170k 26.99
2022-03-31 $2.5M 75k 34.05
2021-12-31 $3.8M 98k 38.60
2021-09-30 $2.4M 45k 54.00
2021-06-30 $1.1M 35k 33.10
2021-03-31 $50k 2.4k 20.76
2020-12-31 $1.4M 82k 17.53
2020-09-30 $5.8M 394k 14.83